Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer

Figure 3

Receiver-operating characteristic (ROC) curve analyses of exosomal miR-31 (a), miR-192 (b), miR-375 (c), and the combination of the three miRNAs (d) to differentiate GC patients from normal controls. AUC: areas under the curve.

(a)

(b)

(c)

(d)